Biomarkers, CDx & Precision Medicine and NextGen Omics, Tech & Data returns to Basel on 13–14 October 2026, bringing together leading experts from pharma, biotech, academia and healthcare. Across two co-located programmes, the events explore the latest advances in biomarker research, companion diagnostics, precision medicine, multi-omics, data analysis and emerging technologies. Attendees will gain insights into the approaches shaping drug discovery, clinical development and patient stratification, while connecting with industry leaders and technology innovators. With cutting-edge scientific presentations, interactive discussions and opportunities to build meaningful collaborations, the events provide a focused platform to discover new technologies, share expertise and accelerate innovation across precision medicine.